Wolff-Parkinson-White syndrome
ICD-10 I45.6 · ICD-11 BC81.4

Treatment of Wolff-Parkinson-White Syndrome in Pre-Excited Atrial Fibrillation — Haemodynamically Stable Patient

When Wolff-Parkinson-White syndrome presents with pre-excited atrial fibrillation and the patient remains haemodynamically stable, the clinical decision-making follows a distinct pathway from unstable presentations.

Clinical scenario: Pre-excited atrial fibrillation in a haemodynamically stable patient — no signs of haemodynamic instability. The stable status is the defining feature that guides the appropriate management approach.

In this setting, intravenous pharmacological therapy is a recognised option. The complete protocol specifies which agent class is appropriate and the clinical decision points that determine sequencing — these details are available in the full structured regimen below.

Partial treatment overview: Intravenous antiarrhythmic pharmacotherapy may be considered in this stable presentation. The specific agent selection and full management algorithm are not shown here.

Instant Access to Structured Evidence-Based Regimens

References

  • Ibutilide or procainamide (i.v.) should be considered.
  • Flecainide or propafenone (i.v.) may be considered.

DOI: 10.1093/eurheartj/ehz467

View source ↗